Krebs Biochemicals and Industries Limited — Others, 05-02-2025: Copy of Newspaper Publication

Krebs Biochemicals & Industries Limited has announced a board meeting to discuss and approve unaudited financial results for the quarter and nine months ended 31st December 2024. The results reveal total income from operations at ₹11.72 crore, while the net loss before tax stands at ₹7.74 crore, reflecting ongoing financial challenges. This outcome may cast a shadow on investor sentiment, raising concerns about the company's financial health. Nonetheless, investors might view potential operational adjustments as an opportunity for future recovery.